                         SEQUENCE LISTING

<110>  WASHINGTON UNIVERSITY
       XU, Mai
 
<120>  INCOMPATIBLE BLOOD GROUP ANTIGEN FOR CANCER DETECTION AND 
       TREATMENT

<130>  047563-583830

<150>  62/431,795
<151>  2016-12-08

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  431
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  1
gaatacatca ggcaggcaag ggcatcaaga tgaagtcaca gacccaggtc ttcgtatttc       60

tactgctctg tgtgtctggt gctcatggga gtattgtgat gacccagact cccaaattcc      120

tgcttgtctc agcaggagac aggattacca taacctgcaa ggccagtcag agtgtgaata      180

atgatgtagc ttggtaccaa cagaagccag ggcagtctcc taaactgctg atatactatg      240

catccaatcg ctacactgga gtccctgatc gcttcactgg cagtggatat gggacggatt      300

tcactttcac catcaccact gtgaaggctg aagacccggc agtttatttc tgtcagcagg      360

attatagctc tccgctcacg ttcggtgctg ggaccaagct ggaaatcaaa cgtaagtcga      420

ctgcacaact g                                                           431


<210>  2
<211>  143
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  2

Ile His Gln Ala Gly Lys Gly Ile Lys Met Lys Ser Gln Thr Gln Val 
1               5                   10                  15      


Phe Val Phe Leu Leu Leu Cys Val Ser Gly Ala His Gly Ser Ile Val 
            20                  25                  30          


Met Thr Gln Thr Pro Lys Phe Leu Leu Val Ser Ala Gly Asp Arg Ile 
        35                  40                  45              


Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asn Asn Asp Val Ala Trp 
    50                  55                  60                  


Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Tyr Ala 
65                  70                  75                  80  


Ser Asn Arg Tyr Thr Gly Val Pro Asp Arg Phe Thr Gly Ser Gly Tyr 
                85                  90                  95      


Gly Thr Asp Phe Thr Phe Thr Ile Thr Thr Val Lys Ala Glu Asp Pro 
            100                 105                 110         


Ala Val Tyr Phe Cys Gln Gln Asp Tyr Ser Ser Pro Leu Thr Phe Gly 
        115                 120                 125             


Ala Gly Thr Lys Leu Glu Ile Lys Arg Lys Ser Thr Ala Gln Leu 
    130                 135                 140             


<210>  3
<211>  478
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  3
actggtgtgc agtcatgggc agacttacat tctcattcct gctgctgctg cctgtccctg       60

catatgtcct atctcaggtt actctgaaag agtctggccc tgggatattg cagccatcac      120

agacgctgag cctggcctgt actttctctg ggatttcact gagtacttct ggtttgggtt      180

tgagctggct tcgtaagccc tcagggaagg ctttagagtg gctggtaagc atttggccta      240

atgaaaacta cttcaaccca tctttgaaga gccggctcac aatctccaag gtgacctcca      300

acaaccaagt attccttgaa ctcaccagtg tggacactgc agattctgcc acgtactact      360

gtgtttggag agagaagtgg gagggtcact acgaatggtt tgcttactgg ggccaaggga      420

ctctggtcac cgtctctcca gctagcacga cagccccatc ggtcaagggc gaattcgc        478


<210>  4
<211>  158
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  4

Trp Cys Ala Val Met Gly Arg Leu Thr Phe Ser Phe Leu Leu Leu Leu 
1               5                   10                  15      


Pro Val Pro Ala Tyr Val Leu Ser Gln Val Thr Leu Lys Glu Ser Gly 
            20                  25                  30          


Pro Gly Ile Leu Gln Pro Ser Gln Thr Leu Ser Leu Ala Cys Thr Phe 
        35                  40                  45              


Ser Gly Ile Ser Leu Ser Thr Ser Gly Leu Gly Leu Ser Trp Leu Arg 
    50                  55                  60                  


Lys Pro Ser Gly Lys Ala Leu Glu Trp Leu Val Ser Ile Trp Pro Asn 
65                  70                  75                  80  


Glu Asn Tyr Phe Asn Pro Ser Leu Lys Ser Arg Leu Thr Ile Ser Lys 
                85                  90                  95      


Val Thr Ser Asn Asn Gln Val Phe Leu Glu Leu Thr Ser Val Asp Thr 
            100                 105                 110         


Ala Asp Ser Ala Thr Tyr Tyr Cys Val Trp Arg Glu Lys Trp Glu Gly 
        115                 120                 125             


His Tyr Glu Trp Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
    130                 135                 140                 


Ser Pro Ala Ser Thr Thr Ala Pro Ser Val Lys Gly Glu Phe 
145                 150                 155             


